Skip to content

Evms (Enterprise Visual Medical System Software)

by Emageon, Inc.

510(k) K053281

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

9 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK053281 Date7 Dec 2005ClearedStatusActive

Recalls

9 recalls · FDA

    • Terminated Z-0614-2017 FDA Class II initiated 14 Jul 2016

    It was reported by a customer that RadSuite images are not appearing as readable images. This product malfunction has the potential to result in delay in care and a possible re-exposure of the patient to radiation (x-ray).

    • Terminated Z-1470-2017 FDA Class II initiated 4 Apr 2016 on shared 510(k) K053281

    The software produced a number of "do not route" exceptions, which may result in potential patient injury or delay in diagnosis or treatment.

    • Terminated Z-2627-2016 FDA Class II initiated 31 Jan 2016

    Potential for RadSuite AV viewer to skip image slices when the user presses page up or page down when the viewer displays multiple viewports and the user has mouse focused on any viewport other than the first viewport.

    • Terminated Z-2685-2016 FDA Class II initiated 30 Jan 2016

    Interventional Radiology (IR) images are stored as JPEG2k Lossless in Merge Enterprise Archive (EA) and are not displaying correctly in RadSuite.

    • Terminated Z-0794-2016 FDA Class II initiated 17 Dec 2015

    Potential incorrect Standardized Uptake Values (SUV) measurements in RadSuite.

    • Terminated Z-1180-2017 FDA Class II initiated 17 Nov 2015

    The values provided from the Pixel Value tool do not appear to be correct, which may result in potential patient injury or delay in diagnosis or treatment.

    • Terminated Z-2715-2016 FDA Class II initiated 9 Apr 2015

    When RadSuite is used with IPID (Issuer of Patient ID) as a part of the "Patient Identifier," it is possible in some circumstances that the demographics of one patient will be applied to a study or studies for another patient.

    • Terminated Z-2796-2016 FDA Class II initiated 6 May 2013

    Multiple studies were missing at a customer location that never made it to the archive before watermarking

    • Terminated Z-1644-2008 FDA Unclassified (pre-2012) initiated 1 Jan 2008

    Miscalculation: The calculation of the standard uptake value does not include the required calibration factor/decay correction factor. The resulting value is incorrectly calculated, which may lead to incorrect interpretation of tissue density. The calculation error exists in both the software and user guide.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LLZ
Device Class
Class II
Regulation
21 CFR Part 892.2050
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Other devices from Emageon, Inc.